ranolazine has been researched along with Genetic Predisposition in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bargelli, V; Bartolucci, G; Belardinelli, L; Cerbai, E; Coppini, R; Crocini, C; Ferrantini, C; Gentile, F; Laurino, A; Mazzoni, L; Mugelli, A; Olivotto, I; Pioner, JM; Poggesi, C; Rotellini, M; Sacconi, L; Santini, L; Tardiff, J; Tesi, C | 1 |
| Kaufman, ES | 1 |
| McNitt, S; Moss, AJ; Robinson, JL; Rosero, S; Schwarz, KQ; Zareba, W | 1 |
| Atack, TC; Hall, L; Lowe, JS; Roden, DM; Stroud, DM; Yang, T | 1 |
1 trial(s) available for ranolazine and Genetic Predisposition
| Article | Year |
|---|---|
Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.
Topics: Acetanilides; Adolescent; Adult; Electrocardiography; Enzyme Inhibitors; Female; Genetic Predisposition to Disease; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Muscle Proteins; NAV1.5 Voltage-Gated Sodium Channel; Piperazines; Ranolazine; Sodium; Sodium Channels; Treatment Outcome; Young Adult | 2008 |
3 other study(ies) available for ranolazine and Genetic Predisposition
| Article | Year |
|---|---|
Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
Topics: Animals; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Echocardiography, Doppler; Excitation Contraction Coupling; Genetic Predisposition to Disease; Heart Rate; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Membrane Potentials; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Mutation; Myocardial Contraction; Myocytes, Cardiac; Phenotype; Ranolazine; Sodium; Sodium Channel Blockers; Time Factors; Troponin T; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Use of ranolazine in long-QT syndrome type 3.
Topics: Acetanilides; Adolescent; Adult; Electrocardiography; Enzyme Inhibitors; Female; Genetic Predisposition to Disease; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Muscle Proteins; NAV1.5 Voltage-Gated Sodium Channel; Piperazines; Ranolazine; Sodium; Sodium Channels; Treatment Outcome; Young Adult | 2008 |
Increased late sodium current contributes to long QT-related arrhythmia susceptibility in female mice.
Topics: Acetanilides; Action Potentials; Animals; Cnidarian Venoms; Disease Models, Animal; Electrocardiography; Female; Genetic Predisposition to Disease; Humans; Long QT Syndrome; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Piperazines; Ranolazine; Risk Factors; Sex Factors; Tachycardia, Ventricular; Time Factors | 2012 |